Conditions: Cardiovascular Disease

Intervention Type: Drug

Intervention Name: placebo

Clinical Trials

The following are clinical trials from the Healia Clinical Trials Information Database that are researching the effect of the "Drug" intervention "placebo" on "Cardiovascular Disease".

• Effects of Pioglitazone in Patients With Type 2 Diabetes Mellitus and Coronary Heart Disease at High Risk for Vascular Complications : A Placebo-Controlled Study

  NCTID: NCT00479986

• Effects of 3 Months of SSRI-Treatment on Metabolism and HPA-axis in Young Men Born With Low Birth Weight - a Randomized, Double Blinded and Placebo-controlled Trial

  NCTID: NCT00971815

• Effect of Maraviroc on Endothelial Function in HIV-Infected Patients

  NCTID: NCT00844519

• Randomized, Multinational, Multicenter, Double-blind, Placebo-controlled, Two-arm Parallel Group Trial of Rimonabant 20 mg OD for Reducing the Risk of Major Cardiovascular Events in Abdominally Obese Patients With Clustering Risk Factors

  NCTID: NCT00263042

• INSTANT: INtegrilin Plus STenting to Avoid Myocardial Necrosis Trial

  NCTID: NCT00638976

• A Parallel Randomized Controlled Evaluation of Clopidogrel Plus Aspirin, With Factorial Evaluation of Irbesartan, for the Prevention of Vascular Events, in Patients With Atrial Fibrillation

  NCTID: NCT00249795

• Prevention of Hypertension in Patients With Pre-hypertension: PREVER-prevention Study

  NCTID: NCT00970931

• A Hazardous Combination of Cigarette Smoking and Bronchodilation in Chronic Obstructive Pulmonary Disease

  NCTID: NCT00981851

• Can Dipyridamole Induce Protection Against Ischemia and Reperfusion Injury in Patients Undergoing Elective CABG?

  NCTID: NCT01295567

• Effect of Ulinastatin on Postoperative Systemic Inflammatory Response in Cardiac Surgery

  NCTID: NCT01518569

---